These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8431339)

  • 1. In vitro effect of ephedrine, adrenaline, noradrenaline and isoprenaline on halothane-induced contractures in skeletal muscle from patients potentially susceptible to malignant hyperthermia.
    Urwyler A; Censier K; Seeberger MD; Rothenbühler JM; Kaufmann MA; Drewe J
    Br J Anaesth; 1993 Jan; 70(1):76-9. PubMed ID: 8431339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro muscle contractures induced by halothane and suxamethonium. II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients.
    Fletcher JE; Rosenberg H
    Br J Anaesth; 1986 Dec; 58(12):1433-9. PubMed ID: 3790395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential effect of halothane and 1,2-dichlorohexafluorocyclobutane on in vitro muscle contractures of patients susceptible to malignant hyperthermia.
    Kindler CH; Girard T; Gong D; Urwyler A
    Anesth Analg; 2002 Apr; 94(4):1028-33, table of contents. PubMed ID: 11916818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients.
    Wappler F; Scholz J; Fiege M; Richter A; Steinfath M; Weisshorn R; Schulte am Esch J
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):376-81. PubMed ID: 10551274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity.
    Fletcher JE; Rosenberg H
    Anesthesiology; 1985 Aug; 63(2):190-4. PubMed ID: 4025868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.
    Ilias WK; Williams CH; Fulfer RT; Dozier SE
    Br J Anaesth; 1985 Oct; 57(10):994-6. PubMed ID: 4041327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Bay K 8644 on the magnitude of isoflurane and halothane contracture of skeletal muscle from patients susceptible to malignant hyperthermia.
    Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyford H; Imbenotte M
    Anesthesiology; 1992 Apr; 76(4):544-9. PubMed ID: 1372490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of calcium-free solution, calcium antagonists, and the calcium agonist BAY K 8644 on mechanical responses of skeletal muscle from patients susceptible to malignant hyperthermia.
    Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Reyford H; Cordonnier C; Haudecoeur G
    Anesthesiology; 1991 Sep; 75(3):413-9. PubMed ID: 1716078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
    Sato N; Brum JM; Mitsumoto H; DeBoer GE
    Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of halothane on the mechanical responses in vitro of coronary arterial rings of malignant hyperthermia susceptible swine.
    DeRoth L; Nadeau S
    J Vet Pharmacol Ther; 1988 Dec; 11(4):402-4. PubMed ID: 3210267
    [No Abstract]   [Full Text] [Related]  

  • 12. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for malignant hyperpyrexia.
    Nelson TE; Austin KL; Denborough MA
    Br J Anaesth; 1977 Feb; 49(2):169-72. PubMed ID: 836748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xenon does not induce contracture in human malignant hyperthermia muscle.
    Baur CP; Klingler W; Jurkat-Rott K; Froeba G; Schoch E; Marx T; Georgieff M; Lehmann-Horn F
    Br J Anaesth; 2000 Nov; 85(5):712-6. PubMed ID: 11094586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of susceptibility to malignant hyperpyrexia in swine.
    Okumura F; Crocker BD; Denborough MA
    Br J Anaesth; 1979 Mar; 51(3):171-6. PubMed ID: 435338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Na(+)-Ca2+ exchange influences halothane and caffeine contractures of malignant hyperthermic skeletal muscle.
    Williams JH; Lee JC; Holland M
    Res Commun Chem Pathol Pharmacol; 1992 Aug; 77(2):253-6. PubMed ID: 1439194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diltiazem and nifedipine reduce the in vitro contracture response to halothane in malignant hyperthermia-susceptible muscle.
    Adnet PJ; Krivosic-Horber RM; Haudecoeur G; Reyford HG; Adamantidis MM; Dupuis BA
    Can J Anaesth; 1990 Jul; 37(5):556-9. PubMed ID: 2372858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of benzamil on in vitro contracture responses of human skeletal muscle to halothane.
    Hopkins PM; Ellis FR; Halsall PJ
    Gen Pharmacol; 1994 Jan; 25(1):23-9. PubMed ID: 8026710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
    Ording H; Bendixen D
    Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
    Sudo RT; Nelson TE
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.